101 / 110
251
Tabaco y peso corporal
S. Does combination pharmacological intervention for
smoking cessation prevent post-cessation weight gain?
A systemic review. Addictive Behaviors 2013; 38: 1865-
75.
2.- Strong DR, David SP, Johnstone EC, Ave-
yard P, Murphy MF, Munato MR. Differential
Efficacy of Nicotine Replacement Among Overweight
and Obese Women Smokers. Nicotine Tob Res 2015;
17: 855-61.
3.-
Bush T, Levine MD, Magnusson B, Cheng
Y, Chen X, Mahoney L, et al
. Impact of Baseline
Weight on Smoking Cessation and Weight Gain in Quit-
lines.
Ann Behav Med 2014; 47: 208-17.
4.- Ben Taleb Z, Ward KD, Asfar T, Jaber R,
Bahelah R, Maziak W. Smoking Cessation and
Changes in Body Mass Index: Findings From the First
Randomized Cessation Trial in a Low-Income Coun-
try Setting. Nicotine Tob Res. 2017 ;19:351-6. doi:
10.1093/ntr/ntw223.
5.- Farley AC, Hajek P, Lycett D, Aveyard
P.
Interventions for preventing weight gain alter
smoking cessation (Review). Cochrane Database of
Systematic Reviews 2012, Jan 8;1:CD006219. doi:
10.1002/14651858.
6.- Bush T, Levine MD, Beebe LA, Cerutti B,
Deprey M, McAfee T, et al. Addressing Weight
Gain in Smoking Cessation Treatment: A Randomized
Controlled Trial. Am J Health Promot 2012; 27: 94-102.
7.- Anderson J, Greenway F, Fujioka K, et
Gadde KM, McKenney J, O’Neil PM. Bupro-
pion SR enhances weight loss: A 48-week double-blind,
placebo-controlled trial. Obes Res 2002; 10: 633-41.
8.- Beard E, Shahab L, Cummings DM, Michie
S, West R. New Pharmacological Agents to aid Smok-
ing Cessation and tobacco Harm Reduction: What Has
Been Investigated, and What Is in the Pipeline? CNS
Drugs 2016; 30: 951-83.
9.- Levin ED, Johnson JE, Slade S, Wellis
C, Cauley M, Petro A, et al. A 5-HT2C agonist,
decreases nicotine self-administration in female rats. J
Pharmacol Exp Ther 2011; 338: 890-6.
10.- Greenway FL, Shanahan W, Fain R, Ma T,
Rubino D. Safety and tolerability review of lorcaserin
in clinical trials. Clin Obes 2016; 6: 285-95.
11.- Panakova A, Kralikova E, Kavalkova P,
Stepankova L, Zvolska K, Haluzik M. No
change in serum incretins levels but rise of leptin levels
after smoking cessation: a pilot study. Physiol Res 2016;
65: 651-9.
12.- Pi-Sunyer X, Astrup A, Fujioka K, Green-
way F, Halpem A, Rempf M, et al. A Random-
ized, Controlled Trial of 3.0 mg of Liraglutide in weight
management. N Engl J Med 2015; 373: 11-22.
13.- Kang JG, Park CY, Kang JH, Park YW, Park
SW. Randomized controlled trial to investigate the ef-
fects of a newly developed formulation of phentermine
diffuse-controlled release for obesity. Diabetes Obes
Metab 2010; 12: 876-82.
Correspondencia a:
Dra. María José Escaffi F.
Email: mescaff
i@clc.cl
Rev Chil Enferm Respir 2017; 33: 249-251